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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYProgesterone drivesmammary stem and progenitor cell dynamics through paracrinemechanisms that are currently not well understood.
Here, we demonstrate that CXCR4, the receptor for stromal-derived factor 1 (SDF-1; CXC12), is a crucial instructor of hormone-induced
mammary stem and progenitor cell function. Progesterone elicits specific changes in the transcriptome of basal and luminal mammary
epithelial populations, where CXCL12 and CXCR4 represent a putative ligand-receptor pair. In situ, CXCL12 localizes to progesterone-
receptor-positive luminal cells, whereas CXCR4 is induced in both basal and luminal compartments in a progesterone-dependent
manner. Pharmacological inhibition of CXCR4 signaling abrogates progesterone-directed expansion of basal (CD24+CD49fhi) and
luminal (CD24+CD49flo) subsets. This is accompanied by a marked reduction in CD49b+SCA-1 luminal progenitors, their functional
capacity, and lobuloalveologenesis. These findings uncover CXCL12 and CXCR4 as novel paracrine effectors of hormone signaling in
the adult mammary gland, and present a new avenue for potentially targeting progenitor cell growth and malignant transformation
in breast cancer.INTRODUCTION
Cumulative lifetime hormone exposure as a result of natu-
ral menstrual cycles and exogenous hormone therapies is a
strong determinant of increased breast cancer risk. Proges-
terone, an ovarian steroid hormone that peaks during the
luteal phase of the menstrual cycle, promotes the expan-
sion of stem and progenitor cells in the mammary gland
(Joshi et al., 2010, 2012). Given their multipotency, self-
renewal, proliferative properties, and shared molecular
signatures with specific breast cancer subtypes, mammary
stem and progenitor cells have been proposed to be cellular
targets of transformation in breast cancer (Visvader, 2011).
Since hormones play an integral role in breast cancer devel-
opment and stem cell control, an in-depth understanding
of the mechanisms responsible for hormone action on
distinct cell types in the mammary gland is highly war-
ranted. Through global transcriptomic analyses of purified
mammary epithelial subsets (basal, luminal, and stromal)
followed by phenotypic and functional studies, we identify
and validate CXCR4 as a critical mediator of progesterone
signaling in the adult mammary gland.
CXCR4, together with its ligand, CXCL12, is well known
for its role in regulating the migration of hematopoietic
stem cells to the bone marrow, and controlling their quies-Stem Ccence, proliferation, and recruitment to the circulation
(Honczarenko et al., 2006; Lapidot and Kollet, 2002).
Further, CXCR4 and CXCL12 promote metastasis in
several cancers, including breast cancer, where they are
associated with tamoxifen resistance and poor prognosis
(Mukherjee and Zhao, 2013). Our study reveals a previously
uncharacterized nexus between CXCR4 and progesterone
signaling that drives the recruitment of mammary stem
and progenitor cells during epithelial expansion and lobu-
loalveolar regeneration.RESULTS AND DISCUSSION
Progesterone Induces Distinct Molecular Programs in
Mammary Cell Compartments
Mammary stem cells within the basal epithelium and
CD49b+SCA-1 luminal progenitors are both hormone-re-
ceptor negative (HR) (Asselin-Labat et al., 2006; Shehata
et al., 2012), and we hypothesized that these cells respond
to ovarian hormones via paracrine signals provided by HR+
luminal cells. To delineate the full spectrum of hormone-
induced changes in the adult mammary gland, we gener-
ated microarray expression profiles of fluorescence-acti-
vated cell sorting (FACS)-purified basal (CD24CD49fhi),ell Reports j Vol. 4 j 313–322 j March 10, 2015 j ª2015 The Authors 313
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luminal (CD24+CD49flo), and stromal (CD24CD49f)
mammary cells from mice (Figure 1A) under defined hor-
mone treatments (progesterone [P], 17b-estradiol [E], and
17b-estradiol plus progesterone [EP]) or vehicle controls.
Unsupervised hierarchical clustering revealed a strong
concordance within each cellular compartment, with
tighter clustering among EP-treated samples compared
with E, P, and vehicle treatments (Figure 1B). Visualization
of hormone effects via volcano plots and Venn diagrams
indicated that there were more differentially expressed
genes in luminal and basal cells in the EP samples than in
either the E or P samples alone, compared with vehicle
(p < 2.2 3 1016; proportions test; Figures 1C, 1D, S1A,
and S1B). These data are tabulated in Figure S1C. Notably,
treatment of mice with P alone had a limited effect on
gene expression (Figures 1C and S1A–S1C). This is likely
because estrogen is required to drive expression of the pro-
gesterone receptor (PR) in adult mice. Venn diagrams also
illustrate greater overlap between basal and luminal cells af-
ter EP treatment versus E or P alone (Figures 1D and S1A).
These data suggest that a combination of E and P generates
more robust cellular responses, and these changes occur
primarily in the epithelial subsets rather than in the stro-
mal fraction.
To identify progesterone-driven networks associated
with mammary stem and progenitor cell expansion,
we analyzed genes identified as significantly altered
(q value < 0.05, jfold-changej R 1.5) in specific compart-
ments following EP treatment using GOMiner software
(threshold of 10% false-discovery rate [FDR]; Figure 1E).
The basal population was enriched for alterations in the
cell-adhesion pathway, consistent with these cells express-
ing high levels of b1 (CD29) and a6 (CD49f) integrins
(Shackleton et al., 2006; Stingl et al., 2006). Integrins facil-
itate adhesion, and b1 integrin is important for maintain-
ing stem cell activity within specialized niches (Taddei
et al., 2008). Interestingly, ovarian hormones regulate
expression of integrins during mammary morphogenesis,
with a5b1 integrin increasing following puberty, in early
pregnancy, and in response to EP treatment (Haslam and
Woodward, 2001). Luminal cells were enriched for genesFigure 1. Computational Analyses of Microarray Expression Profil
(A) Schema of experimental pipeline.
(B) Heatmaps display levels of mRNA expression with a variance of >
(C) Volcano plots of differential mRNA abundance levels following hor
from linear model in log2 scale; y axis: p values adjusted for multiple
(D) Venn diagram of significant genes with q value < 0.05 and jfold-c
(E) Dotmap of significant progesterone-responsive pathways in differe
are represented by the shade of the gray boxes, and log2 enrichment
(F) Independent qPCR validation of FACS-sorted basal and luminal sam
based on two-tailed unpaired t test, *p < 0.05.
See also Figure S1.
Stem Cinvolved in cell-cycle and chromosomal regulation, sug-
gesting that EP exerts direct mitogenic effects on this pop-
ulation. This finding agrees with reports that progesterone
elicits two waves of cellular proliferation in the mammary
epithelia, with the first occurring in PR+ luminal cells
(Beleut et al., 2010). In contrast, expression analyses of
the stromal compartment indicated an enrichment of
pathways involved in extracellular matrix (ECM) regula-
tion in response to EP, consistent with data suggesting
that progestin has the capacity to modify the ECM compo-
sition (Xie and Haslam, 1997). An examination of the
top 25 common pathways altered by EP across all three
cell populations suggested that more similar pathways
are regulated by progesterone in basal and luminal cells
compared with the stroma (Figure S1D). Gene set enrich-
ment analysis (GSEA) was also performed and was largely
consistent with the GOMiner results (Figure S1E). GSEA
also showed basal cells to be enriched for metabolic and
ATP synthesis pathways, luminal cells for DNA repair,
and stromal cells for translation and receptor signaling
pathway (Figure S1E).
CXCR4 Induction Occurs in Lobuloalveoli and
Requires PR
We next interrogated our significantly altered EP gene lists
from basal, luminal, and stromal compartments using an
online database (Database of Ligand-Receptor Partners
[DLRP]) to seek ligand and receptor pairs that are likely
involved in progesterone-driven stem and progenitor cell
activation (Graeber and Eisenberg, 2001). CXCL12-
CXCR4 was identified as a potential pathway involved in
progesterone-initiated paracrine signaling. Although the
CXCL12 cytokine is known to function in stem cell ho-
meostasis and breast cancer progression, little is known
about its role in mammary epithelial cell fate and control
by steroid hormone signaling. To validate changes in the
CXCL12-CXCR4 axis observed in microarray profiles, we
performed quantitative RT-PCR (qRT-PCR) analyses in
independently sorted samples of luminal and basal epithe-
lial populations. Consistent with global effects on gene
expression, we confirmed that Cxcr4 was significantlyes of Mammary Subsets and mRNA Level Validation
3 across all 40 samples.
mone treatments in distinct cell compartments. X axis: coefficients
testing. The red dotted line depicts q value < 0.05.
hangejR 1.5.
nt cell populations as determined by GOMiner analyses. FDR values
scores are indicated by the size of the circle within each box.
ples. Mean ± SEM, EP n = 4, E n = 3 mice/group. Significance levels
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Figure 2. Mammary Epithelial Expression of CXCR4 and CXCL12 in Response to Hormones
(A) CXCR4 staining (green) was scored in ductal versus alveoli structures. Co-localization of CXCR4 with the basal marker K14 (red, top
panels), luminal marker K18 (red, middle panels), and CXCL12 (red, bottom panels) is shown under synthetic hormone treatments and
natural estrous cycle. DAPI (blue) stain indicates cell nucleus; scale bar, 50 mm.
(B) Intensity of CXCR4 staining was separated into four groups (high, medium, low, and negative) using Definiens Tissue Studio software.
(C) Bar graph shows the percentage of mammary epithelial cells that possess CXCR4 intensities in each group.
(D) Bar graph shows the percentage of CXCR4+ cells (high + medium group) in total mammary epithelia; mean ± SEM; EP n = 4, E n = 3,
diestrus n = 3 and estrus n = 4 mice/group. Significance levels based on two-tailed unpaired t test; *p < 0.05, **p < 0.01.
See also Figure S2.upregulated in the basal population in response to EP (Fig-
ure 1F), but not following treatment with E or P alone
(Figure S1F).316 Stem Cell Reports j Vol. 4 j 313–322 j March 10, 2015 j ª2015 The AuthImmunofluorescence demonstrated that CXCR4 protein
localized to the nucleus in both the E and EP treatment
groups (Figure 2A). CXCR4 is a G-protein-coupled receptorors
(GPCR) that is typically found on the cell surface; however,
Wang et al., (2009) showed that activated CXCR4 can
translocate to the nucleus and mediate transcriptional
changes. Co-staining of CXCR4 with basal (K14) and
luminal (K18) cytokeratin markers confirmed its expres-
sion in both luminal and basal cells (Figure 2A).
Conversely, CXCL12 staining was observed in the cyto-
plasm of luminal cells (Figure 2A). This stainingwas hetero-
geneous where strong CXCL12 expression overlappedwith
high expression of the differentiation marker K8 and with
PR (Figure S2). These data indicate that CXCL12 is primar-
ily expressed inHR+ luminal subpopulations, as opposed to
the CD49b+SCA-1 luminal subset, which is known to be
ERPR and enriched for progenitor cells.
Spatial differences between CXCR4 and its ligand
CXCL12 in the mammary gland suggest that CXCR4 and
CXCL12 are adequately positioned for autocrine and para-
crine signaling in luminal and basal cells, respectively.
CXCR4 signal intensities were quantified with the use of
Definiens Tissue Studio software and categorized as high,
medium, low, or negative; high- and medium-intensity
groups were considered to represent a positive signal (Fig-
ures 2B and 2C). Since progesterone signaling leads to
the formation of sac-like alveolar structures that function-
ally differentiate to secrete milk during pregnancy and
lactation (Fata et al., 2001; Joshi et al., 2010), ductal
and alveolar structures were individually scored in EP-
treated glands. Only ducts were quantified in E-treated
glands, because such ducts are devoid of alveoli. Signifi-
cantly more CXCR4+ cells were present in EP alveoli struc-
tures (84.9% ± 6.3%, n = 3) compared with EP (33.3% ±
12.6%, n = 4, p = 0.022) and E (26.9% ± 17.0%, n = 3,
p = 0.038) ductal structures, suggesting that progesterone-
induced CXCR4 acts primarily within alveolar structures
(Figure 2D).
The spatial relationship of CXCR4 andCXCL12was then
examined during the estrus (progesterone-low) and dies-
trus (progesterone-high) stages of the murine estrous cycle.
Again, nuclear staining of CXCR4 was observed in luminal
and basal cells, whereas CXCL12 expression was cyto-
plasmic and restricted to the luminal population (Fig-
ure 2A). More CXCR4+ cells were seen in diestrus alveoli
structures (78.2% ± 6.2%, n = 3) compared with diestrus
(46.5% ± 5.6%, n = 3, p = 0.007) and estrus (27.8% ±
13.2%, n = 4, p = 0.016) ductal structures, demonstrating
lobuloalveoli enrichment of CXCR4 in this physiological
state (Figure 2D). Thus, progesterone uniquely induces
CXCR4+ cells in the luminal and basal compartments of
lobuloalveoli, whereas CXCL12 remains confined to
luminal cells.
To determine whether CXCL12-CXCR4 signaling within
the luminal compartment involves an autocrine or para-
crine mode of cellular crosstalk, we used the PR-LacZStem Creporter mouse to determine whether CXCR4 was prefer-
entially expressed in HR+ or HR luminal cells. We noted
that all cells that were positive for b-galactosidase were
CXCR4+, although CXCR4 positivity was not limited to
this HR+ subset (Figure 3A), indicating the likely presence
of both autocrine and paracrine mechanisms of CXCL12
action within luminal cells. We reasoned that if progester-
one signaling through PR is essential for CXCR4 expres-
sion, depletion of this GPCR would be observed in the
mammary glands of PR-null mice (PRKO). Compared
with mammary tissues from wild-type (WT) EP-treated
mice, minimal CXCR4 staining was seen in glands from
EP-treated PRKO mice, confirming the requirement of a
functional PR for CXCR4 expression in the adultmammary
gland (Figure 3A).
CXCR4 Inhibition Abrogates Luminal Progenitor
Expansion and Mammopoiesis
We next determined whether CXCR4 is important for
mammary stem and progenitor cell function in the adult
gland, using two CXCR4 inhibitors with distinct modes
of action: AMD3100 andAMD3465. Previous studies found
that only specific cell types in themammary gland, termed
progenitor cells, can contribute to colony formation
in vitro (Shehata et al., 2012). Both CXCR4 inhibitors
decreased mammary clonogenic capacity (total, luminal,
and basal) by 20% following EP treatment, whereas the
clonogenic capacity of E-treated mammary epithelial pop-
ulations remained unchanged (Figures 3C, 3D, and S3).
These data indicate that a proportion of progenitor cells
in the luminal and basal populations that expand in
response to progesterone are functionally dependent on
CXCR4, which is consistent with the elevated CXCR4
expression observed in the progesterone-stimulated state
(see above, Figure 2D). Application of CXCR4 inhibitors
to cells derived from EP-treated PRKOmice (total, luminal,
and basal) did not result in significant differences in col-
ony-forming capacity, attesting to the importance of intact
PR signaling for CXCR4-mediated effects on mammary
progenitors (Figure 3C).
We then investigated whether CXCR4 signaling is essen-
tial for progesterone effects in the mammary gland in vivo.
Mice were treated concurrently with EP and AMD3100
(18 mg/kg/day and 6 mg/kg/day) for 2 weeks, followed
by mammary cell dissociation and phenotypic analyses
of mammary epithelial subsets (Figure 4A). The effects of
AMD3100 on peripheral white blood cell counts were
measured as a control (Figure S4). CXCR4 inhibition re-
sulted in a significant attenuation in the number of
CD24+CD49flo luminal cells and CD24CD49fhi basal cells
(at the higher concentration) compared with PBS-treated
controls (p < 0.01 and p < 0.021, respectively; Figure 4B).
The luminal epithelial population was further segregatedell Reports j Vol. 4 j 313–322 j March 10, 2015 j ª2015 The Authors 317
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Figure 3. Effects of CXCR4 Inhibition on
Total, Luminal, and Basal Clonogenic
Capacity
(A) Left panel shows in situ staining of
b-galactosidase (red) and CXCR4 (green) in
PR-LacZ reporter mice. Arrowheads mark PR+
cells and arrows mark PRCXCR4+ cells.
Right panels compare CXCR4 expression in
EP WT and PRKO tissue sections. DAPI (blue)
indicates cell nucleus. Scale bars, 20 mm.
(B) Experimental outline for colony-forming
assay.
(C) CXCR4 inhibition with AMD3100 (1 mm)
of total, luminal, and basal colony-forming
capacity in WT (EP n = 4, E n = 4 mice) and
PRKO mice (EP n = 4 mice) compared with
control. Mean ± SEM; significance levels
based on two-tail paired-wise t test; *p <
0.05, ***p < 0.001.
(D) Plates from luminal and basal colony-
forming assays treated with vehicle or 1 mM
AMD3100. Scale bar, 5 mm.
See also Figure S3.using the cell-surface markers SCA-1 and CD49b to iden-
tify HR progenitor cells (CD49b+SCA-1), HR+ progenitor
cells (CD49b+SCA-1+), and non-clonogenic luminal cells
(CD49bSCA-1+) (Shehata et al., 2012). CXCR inhibitor
treatment led to a profound reduction in the number of
CD49b+SCA-1 progenitor cells and a modest yet signifi-
cant decline in the number of HR+ progenitor cells (p =
0.042 and p = 0.006, respectively; Figure 4B). A profound318 Stem Cell Reports j Vol. 4 j 313–322 j March 10, 2015 j ª2015 The Authreduction in colony-forming capacity (up to 45%) was
observed in total mammary cells taken from mice treated
with CXCR4 inhibitor in vivo (p < 0.05; Figure 4C). Total
mammary cells were also dissociated from mice treated
with vehicle control or 18 mg/kg/day AMD3100 and as-
sayed for their ability to repopulate a cleared mammary
fat pad in vivo (100 injected cells/fat pad, n = 11 mice/
group). Repopulation was observed in 8/11 control miceors
(72.7%) compared with 4/11 AMD3100-treated mice
(36.4%), indicating that inhibition of CXCR4 impedes
the mammary repopulating capacity. Finally, we noted
that gross mammary morphology was compromised in
response to CXCR4 inhibition, with a marked reduction
in side branching and lobuloalveologenesis (Figure 4D).
Taken together, these data suggest that CXCR4-CXCL12
signaling is required for progesterone-mediated effects on
progenitors and lobuloalveolar generation in the adult
mammary gland. Phenotypically, progesterone-stimulated
expansion of epithelial subsets was blocked by CXCR4 in-
hibition; functionally, this translated to a decrease in
mammary progenitor cell numbers and mammopoiesis
in the adult gland.
Conclusions
CXCL12 is a homeostatic chemokine that is integral to the
homing and retention of adult hematopoietic stem cells in
the bone marrow microenvironment, as well as lympho-
cyte trafficking (Honczarenko et al., 2006; Lapidot and
Kollet, 2002). The CXCL12-CXCR4 pathway also operates
in cancer metastasis, with CXCL12 providing a distal
chemotactic signal for metastatic dissemination of tumor
cells to tissues such as the lung, bone, and lymph node
(Mukherjee and Zhao, 2013). Our study demonstrates a
hitherto unknown role of the CXCL12-CXCR4 signaling
pathway in hormone-driven mammary epithelial progen-
itor cell function. Previous work addressing the roles of
CXCR4 in normal breast and breast cancer cell lines found
that CXCR4 affected in vitro progenitor activity (Ablett
et al., 2014). We show that CXCL12 acts in the local mam-
mary microenvironment in vivo, with CXCL12-CXCR4
signaling occurring both within (luminal) and across
(luminal to basal) mammary epithelial subsets in response
to progesterone. In vivo models capture the heterogeneity
of mammary epithelial cell populations while also preser-
ving the numerous cell-cell and cell-matrix interactions
that constitute the mammary stem/progenitor niche
(Joshi et al., 2012). This study positions CXCL12 as a
critical progesterone-stimulated effector whose signaling
is enabled by PR-dependent upregulation of its cognate
receptor, CXCR4, to result in the generation of progenitors
that are indispensable for alveolar development. Under-
standing the programs required for normal adult mammo-
poiesis can provide insight into cellular events and
signaling axes that become deregulated in breast cancer.
Since hormones are known risk factors for breast
cancer development, the discovery of hormone-regulated
signaling processes that impinge on mammary stem and
progenitor cells can potentially be harnessed to develop
molecular therapies aimed at uncoupling the crosstalk be-
tween hormones and cellular precursors involved in breast
cancer.Stem CEXPERIMENTAL PROCEDURES
Mice
All mouse experiments were conducted according to guidelines
from the Canadian Council for Animal Care under protocols
approved by the Animal Care Committee of the Princess Mar-
garet Cancer Centre, Toronto, Canada. FVB mice were used for
all experiments except those involving PRKO mice and WT litter-
mate controls (Ismail et al., 2002). For microarray analyses, mice
were ovariectomized and treated with vehicle or hormones as pre-
viously described (Joshi et al., 2010). Briefly, pellets of 0.14 mg
17b-estradiol (E) or 0.14 mg 17b-estradiol + 14 mg progesterone
(EP) (Innovative Research of America) were inserted subcutane-
ously for 14 days. Alzet osmotic pumps (model 2002; Alza)
were used to deliver AMD3100 (or PBS control) and inserted
with an EP pellet in vivo according to the manufacturer’s
instructions.
FACS Analyses and Colony Assays
Mammary glands were minced for 2 min followed by enzymatic
digestion (Dulbecco’s modified Eagle’s medium: F12 [1:1],
750 Uml1 collagenase/hyaluronidase, 1.5 hr at 37C, samples
vortexed briefly after 1 and 1.5 hr). Single-cell-suspension
preparation and FACS analyses were performed as described by
Joshi et al. (2010) and Shehata et al. (2012), using single
color controls for compensation and established gating strategies
based on Fc isotype-negative controls. Colony-forming assays
were performed with irradiated NIH 3T3 cells according to She-
hata et al., (2012) and cultured at 3% oxygen to allow basal col-
ony growth.
Microarray Preparation and qPCR Analyses
RNA isolation, cDNA conversion, and amplification were per-
formed as described in Joshi et al. (2010). For microarray analyses,
three to four biological replicates were generated for each subset
and hormone treatment. Samples were hybridized to Agilent
mouse GE 8 3 60 K two-color platforms with mouse universal
reference RNA. qPCR was performed as described in Joshi et al.
(2010) or using SYBR Green (Quanta). Primer sequences are pro-
vided in Supplemental Experimental Procedures.
Data Preprocessing and Identification of Signature
Genes
Preprocessing and statistical analyses of rawAgilent Feature Extrac-
tion data files were performed within the R statistical environment
(v2.15.2) using the limma library (v3.14.3) (Smyth, 2004; Smyth
and Speed, 2003) packages of the BioConductor open-source proj-
ect (Gentleman et al., 2004). Control probes were filtered before
background correction (normexp with offset 50) was conducted.
Log ratios from Cy3 and Cy5 were loess normalized within each
array, and scale normalized between arrays. After preprocessing,
mRNA expression was analyzed using the univariate linear model.
All model-based t tests were corrected using empirical Bayes
moderation of the SE, followed by FDR adjustment for multiple
testing (Storey and Tibshirani, 2003). Genes that showed signifi-
cant differential expression were filtered based on q < 0.05 and
jfold-changejR 1.5.ell Reports j Vol. 4 j 313–322 j March 10, 2015 j ª2015 The Authors 319
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Figure 4. CXCR4 Signaling Inhibition Reduces Mammary Progenitors and Lobuloalveologenesis In Vivo
(A) Schema of in vivo experiments.
(B) Top panels show flow cytometry analysis of mammary subsets: luminal (CD24+CD49flo), basal (CD24CD49fhi), and stromal
(CD24CD49f). Bottom panel shows luminal population subdivided by the CD49b and SCA-1 cell-surface markers. Bar graph depicts
(legend continued on next page)
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Pathway and Receptor-Ligand Pair Analyses
Genes that were significantly affected by EP treatment were
analyzed usingGOMiner (Zeeberg et al., 2003) (build 328, database
build 2011-01) and GSEA (v2.0.13) (Subramanian et al., 2005) to
determine enriched pathways. GSEA results were visualized using
Cytoscape (v.2.8.1) (Shannon et al., 2003). DLRP was downloaded
from http://dip.doe-mbi.ucla.edu/dip/DLRP.cgi, the Database of
Interacting Proteins (Graeber and Eisenberg, 2001), and human
Entrez gene IDs of the receptor and ligand pairs were converted
into mouse Entrez gene IDs using the HomoloGene database
from NCBI (data modified 12/12/2012).
Immunofluorescence and Whole Mount
Immunofluorescence of paraformaldehyde-fixed, paraffin-
embedded tissue sections was performed as described in Joshi
et al. (2010). Antibodies are provided in Supplemental Experi-
mental Procedures. Images were taken on an LSM700 confocal
microscope and processed with Definiens Tissue Studio software
to compare the intensities of the antibody signals.
ACCESSION NUMBER
The GEO accession number for the data reported in this paper is
GSE59558.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and four figures and can be found with this article
online at http://dx.doi.org/10.1016/j.stemcr.2015.01.011.
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